Search

Your search keyword '"Korst R."' showing total 74 results

Search Constraints

Start Over You searched for: Author "Korst R." Remove constraint Author: "Korst R."
74 results on '"Korst R."'

Search Results

1. Oncogenic signaling pathways in the Cancer Genome Atlas

3. Erratum: The Immune Landscape of Cancer (Immunity (2018) 48(4) (812–830.e14), (S1074761318301213), (10.1016/j.immuni.2018.03.023))

8. F-118COMPARISON OF OUTCOMES BETWEEN NEUROENDOCRINE THYMIC TUMOURS AND OTHER SUBTYPES OF THYMIC CARCINOMAS: A JOINT ANALYSIS OF THE EUROPEAN SOCIETY OF THORACIC SURGEONS (ESTS) AND THE INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP (ITMIG)

17. Distribution of mediastinal lesions across multi-institutional, international, radiology databases

18. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

19. A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples

20. Comprehensive Characterization of Cancer Driver Genes and Mutations

21. Genomic and functional approaches to understanding cancer aneuploidy

22. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

23. Pathogenic Germline Variants in 10,389 Adult Cancers

24. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

25. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas

26. Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

27. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

28. The Immune Landscape of Cancer

29. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

30. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

31. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer

32. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

33. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer

34. Distribution of Mediastinal Lesions Across Multi-Institutional, International, Radiology Databases.

35. Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database.

36. The Integrated Genomic Landscape of Thymic Epithelial Tumors.

37. Computed Tomography Screening for Lung Cancer: Mediastinal Lymph Node Resection in Stage IA Nonsmall Cell Lung Cancer Manifesting as Subsolid and Solid Nodules.

38. Thymic Carcinoma Management Patterns among International Thymic Malignancy Interest Group (ITMIG) Physicians with Consensus from the Thymic Carcinoma Working Group.

39. Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest Group.

40. Robotic gastrectomy and esophagogastrectomy: A single center experience of 105 cases.

41. The International Thymic Malignancy Interest Group thymic initiative: a state-of-the-art study of thymic malignancies.

42. Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer.

43. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.

44. A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results.

45. An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer.

46. Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity.

47. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy.

48. Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene.

49. Appropriate surgical treatment of resectable non-small-cell lung cancer.

50. Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery.

Catalog

Books, media, physical & digital resources